Instrumento Inactivo

Otros idiomas Physiomics Plc London S.E.

Acciones

Precio de cierre London S.E. Otros sitios de cotización
- ^GBX	-

31/05	El científico jefe de Physiomics dimite	MT
31/05	El Dr. Christophe Chassagnole cesa como director y como director científico de Physiomics plc	CI

Physiomics Chief Scientist Steps Down	31/05
Dr. Christophe Chassagnole Step Down as Director and as Chief Scientific Officer of Physiomics plc	31/05
Physiomics warns large contracts taken longer than expected	03/05
AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal	03/05
Physiomics Plc Increases Revenue Expectation for the Year 2025	03/05
Physiomics Plc Provides Earnings Guidance for the Financial Year Ending 30 June 2024	03/05
Transcript : Physiomics Plc, H1 2024 Earnings Call, Mar 18, 2024	18/03
Physiomics celebrates "substantial" contract with old client	18/03
Physiomics Wins DNA-related Modeling Contract with Large Pharmaceutical Company	18/03
Physiomics plc Wins Contract by an Existing Pharma Client	18/03
Physiomics reports higher interim revenue; loss narrows	07/03
Physiomics Plc Reports Earnings Results for the Half Year Ended December 31, 2023	07/03
Physiomics celebrates contract award for cancer therapy insect model	19/02
The University of Sheffield Selects Physiomics plc to Support a Grant funded Project Focused on an Insect (Fruit Fly) Model of Cancer Treatment	19/02
Physiomics wins deal to support client's oncology assets	05/02
Physiomics plc Announces Contract Award	05/02
Transcript : Physiomics Plc - Special Call	29/01
Physiomics appoints COO Sargent as new CEO; completes restructuring	22/01
Physiomics Names CEO as Chairman	22/01
Physiomics plc Announces Chief Executive Officer Changes	22/01

No hay resultados para esta búsqueda